Middleton, WI, United States of America

Margherita T Cantorna

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Wisconsin Alumni Research Foundation, The Penn State Research Foundation. Active years: 1998-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Margherita T Cantorna. Retrieved from https://idiyas.com/inventor/margherita-t-cantorna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 80.0

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Middleton, WI (US) (1998 - 2000)
  • State College, PA (US) (2004 - 2010)

Company Filing History:


Years Active: 1998-2010

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Margherita T Cantorna: Innovator in Vitamin D Research

Introduction

Margherita T Cantorna is a prominent inventor based in Middleton, WI (US). She has made significant contributions to the field of medical research, particularly in the treatment of inflammatory bowel disease and systemic lupus erythematosus. With a total of 5 patents, her work has the potential to impact many lives.

Latest Patents

One of her latest patents focuses on the treatment of inflammatory bowel disease using 2-methylene-19-nor-vitamin D compounds. This method involves administering a 2-methylene-19-nor-vitamin D compound in an effective amount to treat diseases such as ulcerative colitis and Crohn's disease. Additionally, this administration can prevent or delay the onset of inflammatory bowel disease in susceptible individuals. The preferred compounds in this patent include 1α-hydroxy-2-methylene-19-nor-homopregnacalciferol and 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D. Another significant patent addresses the treatment of systemic lupus erythematosus (SLE). This method involves administering a vitamin D compound to reduce symptoms in SLE patients, demonstrating her innovative approach to tackling complex health issues.

Career Highlights

Throughout her career, Margherita has worked with notable organizations such as the Wisconsin Alumni Research Foundation and the Penn State Research Foundation. Her research has garnered attention for its potential to improve treatment options for patients suffering from chronic conditions.

Collaborations

Margherita has collaborated with esteemed colleagues, including Hector Floyd Deluca and Colleen E Hayes. These partnerships have furthered her research and contributed to the advancement of knowledge in her field.

Conclusion

Margherita T Cantorna's innovative work in vitamin D research highlights her commitment to improving health outcomes for patients with inflammatory bowel disease and systemic lupus erythematosus. Her contributions to science and medicine continue to pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…